Kedudukan dalam Saham
#33455
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Harga Saham
$0.5099
Disegerakkan terakhir: 2024-10-15
Perubahan (1 tahun)
0.00%
Perdagangan Anew Medical, Inc. (WENA)
Harga WENA dengan permodalan pasaran b
Modal pasaran bagi Anew Medical, Inc.(WENA)
Modal Pasaran: $7.60M
Sehingga August 2026, Anew Medical, Inc. mempunyai modal pasaran sebanyak $7.60M. Ini menjadikan Anew Medical, Inc. syarikat ke-33455th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Anew Medical, Inc. dari 2024 hingga 2026
WENA berbanding dengan 5 teratas yang paling popular stocks
| Harga WENA |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.452T
|
+71,731,742.10%
|
|
|
|
|
$4.490T
|
+59,076,428.18%
|
|
|
|
|
$4.162T
|
+54,765,924.71%
|
|
|
|
|
$3.676T
|
+48,370,628.76%
|
|
|
|
|
$2.833T
|
+37,275,082.79%
|
